STUDY FINDS CANCER DRUG PRICING VARIES WIDELY BY GLOBAL DIFFERENCES IN WEALTH
Drug pricing is a big issue in the news, and there is continued controversy surrounding the major differences in patented cancer drug prices around the world. However, the patterns of affordability of these drugs are poorly understood. And although cancer care is undergoing a revolution with the arrival of new therapies such as immunotherapy, monoclonal antibodies, and targeted therapy, prices for cancer drugs vary widely.
San Diego hospitals
Dallas hospitals
San Jose hospitals
A recent study in Oncotarget, 2017, Vol. 8, Issue 42, by Jonathon Clark, Daniel A. Goldstein and others entitled “A global comparison of the cost of patented cancer drugs in relation to global differences in wealth” compared patterns of affordability of cancer drugs in Australia, China, India, Israel, South Africa, the United Kingdom, and the United States to assess whether affordability corresponded to other economic indicators.
Комментарии
Отправить комментарий